Hi Orwell,
Great work as always. Will be watching how this plays out with great interest.
Just going back to the VanEck re-balance, do you have strong opinion either way on the chart of SAR? (same question goes for any of our chartists.)
Having done a bit more analysis, I've discovered that the number of SAR shares held in GDXJ is a much higher % of the average daily volume than most others in the fund. This is important of course, as the buying expected on the rebalance date should have a greater impact to the SP, if there are not enough sellers to take up the slack. So while RRL might have appreciated 35% over the quarter, and SAR 13%, SAR actually may see a bigger move up in the match.
I also really liked SAR fundamentally last time I had a look (a few months back), so it could potentially be an opportunity to build a longer term position...if of course the chart looks good.
@loki01, would love you take on SAR's fundamentals if you have the time or inclination.
Thanks again all
- Forums
- ASX - By Stock
- The Big Boys
Hi Orwell, Great work as always. Will be watching how this plays...
-
-
- There are more pages in this discussion • 600 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add XMD (ASX) to my watchlist
(20min delay)
|
|||||
Last
10,423 |
Change
120.300(1.17%) |
Mkt cap ! n/a |
Open | High | Low |
10,302 | 10,456 | 10,302 |
Featured News
XMD (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Andy Udell, CCO
Andy Udell
CCO
SPONSORED BY The Market Online